Genpact Limited (G) Stock Price & How to Invest

Genpact Limited was spun out of GE's Indian back-office operations in 2005 and has spent two decades running processes that its clients would rather not run themselves: accounts payable, order-to-cash, procurement, claims handling, anti-money-laundering alert review, supply-chain planning and customer service. Revenue comes from long-duration contracts with roughly 800 clients concentrated in banking and capital markets, insurance, consumer goods, life sciences and high-tech manufacturing, delivered by a workforce of around 125,000 people spread across India, the Philippines, Eastern Europe and Latin America. Trailing twelve-month revenue is about ~$5.25 billion, and the business is structurally profitable, with gross margin near ~36.5% and a consistent record of converting earnings into free cash flow, dividends and buybacks.

The investment picture is a race between two lines on the same income statement. Management has reclassified the company as an "agentic and advanced technology solutions" firm, and the Advanced Technology Solutions segment grew more than ~24% year over year in Q2 2026 to roughly ~$363 million, with full-year growth guided at ~25% or better. Against that, the legacy headcount-linked work grows slowly and faces the obvious threat: if an AI agent can clear an invoice exception, the client no longer needs to pay for the seat that used to. Total revenue growth of about ~7% is the net of those two forces. The market has settled on a valuation that assumes the erosion wins, which is why the stock sits near ~$33.86 with a market capitalisation of roughly ~$5.69 billion despite growing earnings at a low-teens rate.

The central risk is that agentic AI compresses the price of the work Genpact performs faster than volumes or new offerings replace it, and analysts have flagged exactly this: ATS may not fully offset a slowing legacy base. A second risk is client concentration and long sales cycles, where a handful of large renewals repriced downward can move a quarter. Currency is a live factor because costs sit largely in Indian rupees and Philippine pesos while revenue is billed mostly in dollars, so moves cut both ways on margin. Immigration and offshoring policy, along with any US tax or visa change targeting outsourced services, is a recurring political exposure for the whole India-delivery cohort. Finally, the cheap multiple is itself information: the market is pricing a business it believes is being disintermediated, and a low valuation offers no protection if that view turns out to be correct.

11 analysts publish price targets on G, averaging $42.18 against a $33.86 price as of August 2026, or +24.6%. The published targets run from $31.00 to $58.00, a moderate spread, and the ratings split 5 buy, 7 hold, 0 sell. Over the last six months there have been 4 raises and 7 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full G forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Genpact Limited. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Advanced Technology Solutions mix shift. ATS reached roughly ~$363 million in Q2 2026, up more than ~24% year over year, and is guided to grow at least ~25% for the full year. The most optimistic published target, $58.00, assumes this works close to its best case.

The case against. The central risk is that agentic AI compresses the price of the work Genpact performs faster than volumes or new offerings replace it, and analysts have flagged exactly this: ATS may not fully offset a slowing legacy base. The most pessimistic target, $31.00, is roughly what G is worth if this bites instead.

Read the full bull and bear case on G, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Genpact Limited's investor relations page or your broker.

• Revenue (TTM): ~$5.25B
• Market cap: ~$5.69B
• Q2 2026 net revenue: ~$1.34B, up ~7.1% year over year
• Q2 2026 adjusted EPS: ~$1.00, up ~13.6%
• Price / trailing revenue: ~1.1x
• Annualised dividend: ~$0.75 per share (~2.2% yield at ~$33.86)

Genpact trades at roughly ~1.1x trailing revenue and high-single-digit to low-double-digit earnings multiples, near the bottom of the IT and business-services group and well below Infosys or Accenture on the same basis. That gap exists because investors are discounting the durability of headcount-linked outsourcing revenue in an AI environment, not because current results are weak: full-year 2026 guidance calls for revenue growth of at least ~7% with Q3 adjusted EPS of roughly ~$1.04 to ~$1.05. The valuation debate is therefore about terminal demand rather than near-term execution.

Other names that sit close to G: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get G exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so G sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where G fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

G is a profitable, cash-generative operations vendor trading at a low multiple, where the question is whether its Advanced Technology Solutions growth arrives faster than AI erodes the headcount-based work underneath it.

Whether G is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is G a buy or a sell?, and where the stock could go from here in the G stock forecast.

For income investors, whether G pays a dividend and how the payout looks is covered in does G pay a dividend? And to weigh G against a peer, read the full side-by-side comparisons: G vs ACN and G vs WIT.